Article: O.2 AXL: A potential therapeutic target to eliminate cancer cells and improve chemotherapeutic responses in different hematological cancers

€3.03

SKU: product-article-15494 Category: General

Description
Reviews (0)

Description

O.2 AXL: A potential therapeutic target to eliminate cancer cells and improve chemotherapeutic responses in different hematological cancers

Reviews

There are no reviews yet.

Be the first to review “Article: O.2 AXL: A potential therapeutic target to eliminate cancer cells and improve chemotherapeutic responses in different hematological cancers”

You must be logged in to post a review.

Top

Article: O.2 AXL: A potential therapeutic target to eliminate cancer cells and improve chemotherapeutic responses in different hematological cancers

Description

Reviews

Related products

Article: Highlights in gynaecological cancers

Article: Calendar of events

Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer

1 year access Online Belgian Journal of Hematology (BJH)